Most COVID-19 prognostic tools only use data given during admission and don’t include changes that occurred after admission, the report said. The study’s researchers developed a machine learning tool to predict severe illness or death in patients with COVID-19 during their first 14 days in the hospital.
The study followed 3,163 patients who were hospitalized between March 5 and Dec. 4, 2020, for being at risk for severe COVID-19. The study took place in five hospitals within the John Hopkins Medicine system in Maryland and Washington, D.C.
The interactive tool developed rapid and accurate probabilities of whether a patient will progress to severe illness or death based on clinical data available. The tool’s purpose is to assist front-line clinicians with prognostic tools to better allocate a hospital’s resources.
More articles on artificial intelligence:
AI could replicate, compound existing disparities in COVID-19 care, study finds
Study: Machine learning can help detect cancer cells by their acidity
Cleveland Clinic, NFL Players Association launch AI venture for neurological diseases
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
